- Open Access
You’ll be a clinician-scientist, my son
© Smeesters. 2015
- Received: 13 August 2015
- Accepted: 25 October 2015
- Published: 4 November 2015
Opinion-based commentary about the complex reality of being a clinician-scientist in today’s modern biomedical environment. The essay uses the beautiful, but old, poem “If” from Rudyard Kipling to draw a parallel with the ambitions, dreams and limits of being a clinical-scientist today.
If you can keep your head when all about you
Are losing theirs and blaming it on you;
And yet don’t look too good, nor talk too wise;
As practitioners, we learn to act during times of acute or prolonged crisis. We try hard to make ourselves strong enough to take responsibility for our actions and provide solutions to patients. Medical training is exigent; so too is the clinical practice which is also very dynamic in nature, with rapid rewards or as rapid disappointments. Whilst aspects of medical practice can sometimes be seen as repetitive, facing the human condition in all its magnificence and weakness is assuredly an inspiring privilege. Although aiming for a cure, practitioners see the limitation of the so-called ‘art of curing’ on a daily basis. If practitioners agree to recognise it, humility is waiting for you at the corner of your practice. Practitioners try to reach the best equilibrium point possible for any given patient. The seemingly ‘better’ or the purported ‘perfect’ is in reality not always the ‘good’ for a particular patient. Doctors therefore listen, observe and finally propose, with a mixture of both cutting-edge knowledge and common sense, a balanced strategy that will usually help the patient in overcoming their medical issue.
If you can dream—and not make dreams your master;
If you can think—and not make thoughts your aim;
If you can meet with Triumph and Disaster
And treat those two impostors just the same;
In both medical practice and scientific research, we have to travel back and forth from dream to reality. If this travel is sometimes tiresome, it is also extremely rich in opportunities. Much can be learned from both ‘Triumph’ and ‘Disaster’. There is, surprisingly, much life in death and successes always are so relative. Time moves rapidly and both successes and failures soon belong to the past. To some extent, acting as a practitioner or a researcher can teach us not to become (too) enslaved to our successes or (too) guilty of our failures. Reconciliation of the opposite is certainly, as in Kipling’s prose, a common lesson we can learn from both appointments.
It is unsurprising that practitioners always have been involved with biomedical progress. Research is everyday and essential in medical practice, particularly for treating patients with rare conditions. To organize, expand and systematize this research activity appears therefore like a natural extension of clinical practice. Moreover, as treating practitioners, doctors have a particular profile for influencing the research agenda. There is little doubt that the position of clinician-scientist appears to be distinctive, necessary and important. A clinician-scientist can provide a unique vision about the contribution that modern science can bring to update medical care. Additionally, both the clinical and scientific working environments, although diverse, are synergistic in nature. Appointing individuals demonstrating some level of expertise in both areas is certainly an interesting opportunity for cross-fertilisation between them.
Undoubtedly, having worked as a scientist has opened new horizons to my clinical practice. Experiencing how little we really know about disease and how vast are the unanswered questions has increased my ability to listen to patients and make them participating members of any decision taken. The less we know, the more room for the patient’s own vision about their condition. This does not mean that each medical option is equally efficient but simply represents a more integrated assessment about the solution each option can provide. In today’s medicine, patients want to be considered as partners and key deciders for their future, and this involvement represents a fantastic and very positive evolution of medical care.
Performing science has also helped me to understand how limited my area of expertise was. We are usually pleased to believe that we know a great deal but experimental science consistently demonstrates how restricted our real understanding is. A natural reaction after facing this ascertainment is to favour multidisciplinary collaborations to solve any given medical problem.
If you can make one heap of all your winnings
And risk it on one turn of pitch-and-toss,
And lose, and start again at your beginnings
And never breathe a word about your loss;
However truly inspiring these verses might be, I cannot read them without adding a ‘but’ to the ‘if’. If determination is certainly a necessary quality for acting as a practitioner or a scientist, the line between stoicism and resistance to change can be thin. And so is the frontier between heroism and stupidity. The reading of this poem touches my soul but it possesses a subtly antiquated and withdrawn sentiment that to me does ring odd. As a clinician, I seriously doubt that forsaking the possibility to converse about our losses constitutes the best option to recover from them. As a scientist, I painfully doubt that it is still possible to lose everything and start again at your beginnings…
Refusing to see how the scientific potential of the clinician-scientist has evolved in today’s science does not elevate the debate. Clinician-scientists no longer drive biomedical research. It is not possible to be truly proficient in both modern clinical care and experimental basic science. In addition, and because they rarely elucidate the latest biological mechanism, their research output will not always be considered as they would have wished by some basic scientists and top tier scientific journals. The constraints of the daily routine of medical practice, including the increasing financial pressure on the health system, lack of time and even the lack of training are major obstacles to the development of broader research activity within academic teaching hospitals. Even if medical training provides us with some scientific knowledge and maybe even more importantly with the interest to learn more about science, it does not make us experimental scientists in and of itself. And if a practitioner decides to devote time to acquire some experience as an experimental scientist, it will happen at the price of their clinical experience and practice.
If neither foes nor loving friends can hurt you,
Yours is the Earth and everything that’s in it,
And - which is more - you’ll be a Man, my son!
Who can really define what to be a clinician-scientist means today? There are as many definitions as there are people embracing this career. Being a clinician-scientist is an incredible position offering many opportunities to construct a multidisciplinary team working on carefully designed research projects addressing patient-oriented problems. Clinician-scientists possess a unique vision about science and can certainly develop research as a means of fulfilment in their work, as well as training in rigor and critical thinking. Clinician-scientists can be, and must remain, knowledge brokers or bridge builders. In our highly specialized medical and research modern environment, they possess an interesting and much needed profile allowing them to make connections between people and expertise. This specific role may be even more important in the future. Of course, such sustained research activity cannot be conceived without full academic freedom and this kind of freedom is rarely given by any institutional power but must rather be taken at all levels—practically, intellectually and financially.
Will I thus really be a clinician-scientist dad? Well, maybe in some aspects and probably in some peoples’ opinion, but with the personal feeling of certainly being a bit of both but definitely not all of each. But that’s absolutely fine, it is fascinating and I like it!
The author declares no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.